Pulse Radiofrequency and Occipital Nerve Block for Chronic Migraine Patients
Comparison of Greater Occipital Nerve Block and Pulse Radiofrequency in Patients With Chronic Migraine
1 other identifier
interventional
70
1 country
1
Brief Summary
In this study, the effect of nerve blockade and radiofrequency treatment applied to the nerve on pain in chronic migraine patients will be investigated. Occipital nerve blockade group (control group): Depending on the location of the pain, blockade will be applied unilaterally or bilaterally with 5 cc of 2% prilocaine for each sıde. Pulse Radiofrequency application to the greater occipital nerve will be applicated after radiofrequency cannula placed near the greater occipital nerve location with 42 degree, for 240 seconds.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 26, 2023
CompletedFirst Submitted
Initial submission to the registry
January 5, 2024
CompletedFirst Posted
Study publicly available on registry
February 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2024
CompletedFebruary 8, 2024
February 1, 2024
6 months
January 5, 2024
February 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Relief
Compare the efficacy of blockade procedure applied to the greater occipital nerve with pulse radiofrequency therapy in terms of pain relief with Visual Analog Scale in chronic migraine patients.The visual analog scale (VAS) is numbered from 0 to 10. 10 is the most severe pain 0: no pain at all
1 and 3 months
Secondary Outcomes (1)
Disability, Quality of life
1 and 3 months
Study Arms (2)
Radiofrequency group
EXPERIMENTALPulse radiofrequency will be applied at 42 degrees for 240 seconds with a channel placed near the greater occipital nerve.
Block group
ACTIVE COMPARATORNerve blockade will be applied to the greater occipital nerve with 5 cc 2% prilocaine.
Interventions
Pulse Radiofrequency application to the greater occipital nerve will be applicated after radiofrequency cannula placed near the greater occipital nerve location at 42 degree, for 240 seconds.
The greater occipital nerve will be blocked with 5 cc 2% prilocaine.
Eligibility Criteria
You may qualify if:
- Patients between 18-60 years of age diagnosed with chronic migraine according to IHS criteria
You may not qualify if:
- Pregnancy
- Major psychiatric disorder
- Bleeding diathesis
- Local infection
- Allergy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Esra Ertilav
Aydin, 09100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Esra Ertilav
Aydin Adnan Menderes University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc.Prof.
Study Record Dates
First Submitted
January 5, 2024
First Posted
February 8, 2024
Study Start
September 26, 2023
Primary Completion
March 10, 2024
Study Completion
April 10, 2024
Last Updated
February 8, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share
YES